Tempus Gets FDA Clearance for Updated AI Cardiac Imaging Tool
Tempus AI, Inc. (NASDAQ: TEM), a expertise firm main the adoption of AI to advance precision drugs, in the present day introduced it has obtained 510(okay) clearance from the U.S. Food and Drug Administration (FDA) for its up to date Tempus Pixel, an AI-powered cardiac imaging platform. This replace permits the era of T1 and…
